Baxter International Inc
$ 27.55
2.00%
07 Aug - close price
- Market Cap 14,243,239,000 USD
- Current Price $ 27.55
- High / Low $ 27.88 / 26.56
- Stock P/E N/A
- Book Value 12.00
- EPS -1.92
- Next Earning Report -
- Dividend Per Share $0.20
- Dividend Yield 0.74 %
- Next Dividend Date 2026-10-01
- ROA 0.03 %
- ROE -0.14 %
- 52 Week High 30.00
- 52 Week Low 15.72
About
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.
Analyst Target Price
$28.12
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-30 | 2026-04-30 | 2026-02-12 | 2025-10-30 | 2025-07-31 | 2025-05-01 | 2025-02-20 | 2024-11-08 | 2024-08-06 | 2024-05-02 | 2024-02-08 | 2023-11-02 |
| Reported EPS | 0.56 | 0.36 | 0.44 | 0.69 | 0.59 | 0.55 | 0.58 | 0.49 | 0.68 | 0.65 | 0.88 | 0.68 |
| Estimated EPS | 0.36 | 0.31 | 0.54 | 0.6 | 0.61 | 0.48 | 0.52 | 0.78 | 0.66 | 0.61 | 0.86 | 0.68 |
| Surprise | 0.2 | 0.05 | -0.1 | 0.09 | -0.02 | 0.07 | 0.06 | -0.29 | 0.02 | 0.04 | 0.02 | 0 |
| Surprise Percentage | 55.5556% | 16.129% | -18.5185% | 15% | -3.2787% | 14.5833% | 11.5385% | -37.1795% | 3.0303% | 6.5574% | 2.3256% | 0% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Oct 2026 | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-10-01 | 2026-07-01 | 2026-04-01 | 2026-01-02 | 2025-10-01 | 2025-07-01 | 2025-04-01 | 2025-01-02 | 2024-10-01 | 2024-07-01 |
| Amount | $0.01 | $0.01 | $0.01 | $0.01 | $0.17 | $0.17 | $0.17 | $0.17 | $0.29 | $0.29 |
Next Dividend Records
| Dividend per share (year): | $0.20 |
| Dividend Yield | 0.74% |
| Next Dividend Date | 2026-10-01 |
| Ex-Dividend Date | 2026-08-28 |
Recent News: BAX
2026-08-07 17:12:00
Baxter International Inc. (BAX) shares increased by 2.00% to $27.55 on Friday, outperforming the broader stock market, which also saw gains. The S&P 500 Index rose 0.62%, and the Dow Jones Industrial Average gained 0.28%. This rise broke a two-day losing streak for Baxter International Inc. stock.
2026-08-07 14:37:14
Cardinal Health (CAH) is facing increased scrutiny due to ongoing Class II recalls of levothyroxine tablets by its affiliate, Major Pharmaceuticals, and the upcoming appointment of a new Chief Accounting Officer, Anita Zielinski. These events raise concerns about the company's quality controls and financial governance. While Cardinal Health's investment narrative typically relies on its scale in distribution, the recalls highlight product integrity as an operational risk, potentially impacting its earnings quality and financial disclosures.
2026-08-07 12:07:26
Andy O'Brien, ConocoPhillips' CFO and EVP of strategy and commercial, is set to become the new CEO, succeeding Ryan Lance on September 1. This move highlights a growing trend of CFOs transitioning to CEO roles, a trend also observed in other Fortune 500 companies. O'Brien's extensive experience across finance, strategy, and operations within ConocoPhillips, along with his long tenure, positions him as a suitable leader for the company.
2026-08-07 07:28:00
Becton Dickinson raised the lower end of its annual adjusted profit forecast for 2026 after exceeding Wall Street estimates for its third-quarter profit and revenue. The company attributed this performance to strong demand for its drug-delivery devices and surgical equipment. Despite potential cost increases from volatile oil prices affecting resin and molded plastics, Becton Dickinson plans to offset these impacts through price increases.
2026-08-07 00:37:12
This article provides a Morningstar analyst report on Baxter International Inc. (BAX), detailing its 2026 outlook, revenue growth, and tariff refund impact. The report, authored by senior analyst Julie Utterback, assigns a rating and fair value to BAX, describing the company's offerings in medical supplies and equipment.
2026-08-07 00:10:35
iRhythm Technologies (IRTC) reported strong Q2 2026 results, exceeding revenue forecasts and demonstrating significant margin expansion, leading to a stock increase. The company announced the acquisition of VitalConnect, which is expected to expand its cardiac monitoring offerings and accelerate its entry into new markets like inpatient monitoring and hospital-to-home care. iRhythm also raised its full-year 2026 revenue and adjusted EBITDA margin guidance, emphasizing continued focus on profitable growth, innovation, and strategic market expansion.
